Medical Care

Global RNAi Medicine Market Research Report 2025

The global market for RNAi Medicine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for RNAi Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNAi Medicine.
The RNAi Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global RNAi Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNAi Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alnylam Pharmaceuticals
Ionis Pharmaceuticals
Suzhou Ribo Life Science Co.,Ltd.
Sirnaomics
GemmaPharma
RiboBio
Segment by Type
siRNA
miRNA
piRNA
Others
Segment by Application
Drug Discovery & Development
Therapeutics
Drug Delivery
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNAi Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNAi Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 siRNA
1.2.3 miRNA
1.2.4 piRNA
1.2.5 Others
1.3 Market by Application
1.3.1 Global RNAi Medicine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Discovery & Development
1.3.3 Therapeutics
1.3.4 Drug Delivery
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNAi Medicine Market Perspective (2020-2031)
2.2 Global RNAi Medicine Growth Trends by Region
2.2.1 Global RNAi Medicine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 RNAi Medicine Historic Market Size by Region (2020-2025)
2.2.3 RNAi Medicine Forecasted Market Size by Region (2026-2031)
2.3 RNAi Medicine Market Dynamics
2.3.1 RNAi Medicine Industry Trends
2.3.2 RNAi Medicine Market Drivers
2.3.3 RNAi Medicine Market Challenges
2.3.4 RNAi Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNAi Medicine Players by Revenue
3.1.1 Global Top RNAi Medicine Players by Revenue (2020-2025)
3.1.2 Global RNAi Medicine Revenue Market Share by Players (2020-2025)
3.2 Global RNAi Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by RNAi Medicine Revenue
3.4 Global RNAi Medicine Market Concentration Ratio
3.4.1 Global RNAi Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNAi Medicine Revenue in 2024
3.5 Global Key Players of RNAi Medicine Head office and Area Served
3.6 Global Key Players of RNAi Medicine, Product and Application
3.7 Global Key Players of RNAi Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 RNAi Medicine Breakdown Data by Type
4.1 Global RNAi Medicine Historic Market Size by Type (2020-2025)
4.2 Global RNAi Medicine Forecasted Market Size by Type (2026-2031)
5 RNAi Medicine Breakdown Data by Application
5.1 Global RNAi Medicine Historic Market Size by Application (2020-2025)
5.2 Global RNAi Medicine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America RNAi Medicine Market Size (2020-2031)
6.2 North America RNAi Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America RNAi Medicine Market Size by Country (2020-2025)
6.4 North America RNAi Medicine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNAi Medicine Market Size (2020-2031)
7.2 Europe RNAi Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe RNAi Medicine Market Size by Country (2020-2025)
7.4 Europe RNAi Medicine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNAi Medicine Market Size (2020-2031)
8.2 Asia-Pacific RNAi Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific RNAi Medicine Market Size by Region (2020-2025)
8.4 Asia-Pacific RNAi Medicine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNAi Medicine Market Size (2020-2031)
9.2 Latin America RNAi Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America RNAi Medicine Market Size by Country (2020-2025)
9.4 Latin America RNAi Medicine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNAi Medicine Market Size (2020-2031)
10.2 Middle East & Africa RNAi Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa RNAi Medicine Market Size by Country (2020-2025)
10.4 Middle East & Africa RNAi Medicine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Details
11.1.2 Alnylam Pharmaceuticals Business Overview
11.1.3 Alnylam Pharmaceuticals RNAi Medicine Introduction
11.1.4 Alnylam Pharmaceuticals Revenue in RNAi Medicine Business (2020-2025)
11.1.5 Alnylam Pharmaceuticals Recent Development
11.2 Ionis Pharmaceuticals
11.2.1 Ionis Pharmaceuticals Company Details
11.2.2 Ionis Pharmaceuticals Business Overview
11.2.3 Ionis Pharmaceuticals RNAi Medicine Introduction
11.2.4 Ionis Pharmaceuticals Revenue in RNAi Medicine Business (2020-2025)
11.2.5 Ionis Pharmaceuticals Recent Development
11.3 Suzhou Ribo Life Science Co.,Ltd.
11.3.1 Suzhou Ribo Life Science Co.,Ltd. Company Details
11.3.2 Suzhou Ribo Life Science Co.,Ltd. Business Overview
11.3.3 Suzhou Ribo Life Science Co.,Ltd. RNAi Medicine Introduction
11.3.4 Suzhou Ribo Life Science Co.,Ltd. Revenue in RNAi Medicine Business (2020-2025)
11.3.5 Suzhou Ribo Life Science Co.,Ltd. Recent Development
11.4 Sirnaomics
11.4.1 Sirnaomics Company Details
11.4.2 Sirnaomics Business Overview
11.4.3 Sirnaomics RNAi Medicine Introduction
11.4.4 Sirnaomics Revenue in RNAi Medicine Business (2020-2025)
11.4.5 Sirnaomics Recent Development
11.5 GemmaPharma
11.5.1 GemmaPharma Company Details
11.5.2 GemmaPharma Business Overview
11.5.3 GemmaPharma RNAi Medicine Introduction
11.5.4 GemmaPharma Revenue in RNAi Medicine Business (2020-2025)
11.5.5 GemmaPharma Recent Development
11.6 RiboBio
11.6.1 RiboBio Company Details
11.6.2 RiboBio Business Overview
11.6.3 RiboBio RNAi Medicine Introduction
11.6.4 RiboBio Revenue in RNAi Medicine Business (2020-2025)
11.6.5 RiboBio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global RNAi Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of siRNA
Table 3. Key Players of miRNA
Table 4. Key Players of piRNA
Table 5. Key Players of Others
Table 6. Global RNAi Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global RNAi Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global RNAi Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global RNAi Medicine Market Share by Region (2020-2025)
Table 10. Global RNAi Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global RNAi Medicine Market Share by Region (2026-2031)
Table 12. RNAi Medicine Market Trends
Table 13. RNAi Medicine Market Drivers
Table 14. RNAi Medicine Market Challenges
Table 15. RNAi Medicine Market Restraints
Table 16. Global RNAi Medicine Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global RNAi Medicine Market Share by Players (2020-2025)
Table 18. Global Top RNAi Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi Medicine as of 2024)
Table 19. Ranking of Global Top RNAi Medicine Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by RNAi Medicine Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of RNAi Medicine, Headquarters and Area Served
Table 22. Global Key Players of RNAi Medicine, Product and Application
Table 23. Global Key Players of RNAi Medicine, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global RNAi Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global RNAi Medicine Revenue Market Share by Type (2020-2025)
Table 27. Global RNAi Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global RNAi Medicine Revenue Market Share by Type (2026-2031)
Table 29. Global RNAi Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global RNAi Medicine Revenue Market Share by Application (2020-2025)
Table 31. Global RNAi Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global RNAi Medicine Revenue Market Share by Application (2026-2031)
Table 33. North America RNAi Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America RNAi Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America RNAi Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe RNAi Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe RNAi Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe RNAi Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific RNAi Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific RNAi Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific RNAi Medicine Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America RNAi Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America RNAi Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America RNAi Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa RNAi Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa RNAi Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa RNAi Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 48. Alnylam Pharmaceuticals Company Details
Table 49. Alnylam Pharmaceuticals Business Overview
Table 50. Alnylam Pharmaceuticals RNAi Medicine Product
Table 51. Alnylam Pharmaceuticals Revenue in RNAi Medicine Business (2020-2025) & (US$ Million)
Table 52. Alnylam Pharmaceuticals Recent Development
Table 53. Ionis Pharmaceuticals Company Details
Table 54. Ionis Pharmaceuticals Business Overview
Table 55. Ionis Pharmaceuticals RNAi Medicine Product
Table 56. Ionis Pharmaceuticals Revenue in RNAi Medicine Business (2020-2025) & (US$ Million)
Table 57. Ionis Pharmaceuticals Recent Development
Table 58. Suzhou Ribo Life Science Co.,Ltd. Company Details
Table 59. Suzhou Ribo Life Science Co.,Ltd. Business Overview
Table 60. Suzhou Ribo Life Science Co.,Ltd. RNAi Medicine Product
Table 61. Suzhou Ribo Life Science Co.,Ltd. Revenue in RNAi Medicine Business (2020-2025) & (US$ Million)
Table 62. Suzhou Ribo Life Science Co.,Ltd. Recent Development
Table 63. Sirnaomics Company Details
Table 64. Sirnaomics Business Overview
Table 65. Sirnaomics RNAi Medicine Product
Table 66. Sirnaomics Revenue in RNAi Medicine Business (2020-2025) & (US$ Million)
Table 67. Sirnaomics Recent Development
Table 68. GemmaPharma Company Details
Table 69. GemmaPharma Business Overview
Table 70. GemmaPharma RNAi Medicine Product
Table 71. GemmaPharma Revenue in RNAi Medicine Business (2020-2025) & (US$ Million)
Table 72. GemmaPharma Recent Development
Table 73. RiboBio Company Details
Table 74. RiboBio Business Overview
Table 75. RiboBio RNAi Medicine Product
Table 76. RiboBio Revenue in RNAi Medicine Business (2020-2025) & (US$ Million)
Table 77. RiboBio Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
Table 81. Authors List of This Report


List of Figures
Figure 1. RNAi Medicine Picture
Figure 2. Global RNAi Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global RNAi Medicine Market Share by Type: 2024 VS 2031
Figure 4. siRNA Features
Figure 5. miRNA Features
Figure 6. piRNA Features
Figure 7. Others Features
Figure 8. Global RNAi Medicine Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global RNAi Medicine Market Share by Application: 2024 VS 2031
Figure 10. Drug Discovery & Development Case Studies
Figure 11. Therapeutics Case Studies
Figure 12. Drug Delivery Case Studies
Figure 13. Others Case Studies
Figure 14. RNAi Medicine Report Years Considered
Figure 15. Global RNAi Medicine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global RNAi Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global RNAi Medicine Market Share by Region: 2024 VS 2031
Figure 18. Global RNAi Medicine Market Share by Players in 2024
Figure 19. Global Top RNAi Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi Medicine as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by RNAi Medicine Revenue in 2024
Figure 21. North America RNAi Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America RNAi Medicine Market Share by Country (2020-2031)
Figure 23. United States RNAi Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada RNAi Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe RNAi Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe RNAi Medicine Market Share by Country (2020-2031)
Figure 27. Germany RNAi Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France RNAi Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. RNAi Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy RNAi Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia RNAi Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries RNAi Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific RNAi Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific RNAi Medicine Market Share by Region (2020-2031)
Figure 35. China RNAi Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan RNAi Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea RNAi Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia RNAi Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India RNAi Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia RNAi Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America RNAi Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America RNAi Medicine Market Share by Country (2020-2031)
Figure 43. Mexico RNAi Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil RNAi Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa RNAi Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa RNAi Medicine Market Share by Country (2020-2031)
Figure 47. Turkey RNAi Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia RNAi Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE RNAi Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Alnylam Pharmaceuticals Revenue Growth Rate in RNAi Medicine Business (2020-2025)
Figure 51. Ionis Pharmaceuticals Revenue Growth Rate in RNAi Medicine Business (2020-2025)
Figure 52. Suzhou Ribo Life Science Co.,Ltd. Revenue Growth Rate in RNAi Medicine Business (2020-2025)
Figure 53. Sirnaomics Revenue Growth Rate in RNAi Medicine Business (2020-2025)
Figure 54. GemmaPharma Revenue Growth Rate in RNAi Medicine Business (2020-2025)
Figure 55. RiboBio Revenue Growth Rate in RNAi Medicine Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies